Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors

Pan, S; Zhan, YH; Chen, XN; Wu, B; Liu, BT

Liu, BT (reprint author), China Med Univ, Shengjing Hosp, Dept Urol, Shenyang, Liaoning, Peoples R China.

FRONTIERS IN ONCOLOGY, 2019; 9 ():

Abstract

Background: Bladder urothelial cancer (BLCA) treatment using immune checkpoint inhibitors (IMCIs) can result in long-lasting clinical benefits. Howeve......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索